Result of upsized oversubscribed BookBuild Offer | 23-May-2025 | 07:00 | RNS |
Increase of BookBuild Offer | 22-May-2025 | 13:44 | RNS |
Result of Placing and Notice of General Meeting | 20-May-2025 | 12:26 | RNS |
Proposed Retail Offer to raise up to £100,000 | 20-May-2025 | 07:02 | RNS |
Proposed Fundraising to raise approximately ... | 20-May-2025 | 07:01 | RNS |
Results for the year ended 31 December 2024 | 20-May-2025 | 07:00 | RNS |
Form 8.5 (EPT/NON-RI) | 25-Feb-2025 | 08:50 | RNS |
Form 8.5 (EPT/NON-RI) | 24-Feb-2025 | 08:48 | RNS |
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc | 21-Feb-2025 | 11:53 | GlobeNewswire NA |
Termination of proposed combination with HOOKIPA | 21-Feb-2025 | 07:00 | RNS |
HOOKIPA Pharma Inc. (“HOOKIPA”) Stat... | 20-Feb-2025 | 20:06 | GlobeNewswire NA |
Form 8.5 Poolbeg Pharma Plc | 20-Feb-2025 | 09:03 | RNS |
Form 8.5 (EPT/NON-RI) | 20-Feb-2025 | 08:53 | RNS |
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc | 20-Feb-2025 | 07:49 | GlobeNewswire NA |
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc | 19-Feb-2025 | 12:35 | GlobeNewswire NA |
Currency | UK Pounds |
Share Price | 2.45p |
Change Today | -0.100p |
% Change | -3.92 % |
52 Week High | 14.25 |
52 Week Low | 2.40 |
Volume | 1,641,474 |
Shares Issued | 500.00m |
Market Cap | £12.25m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 285,487 @ 2.40p |
16:29 | 1 @ 2.50p |
16:28 | 1 @ 2.50p |
16:28 | 1 @ 2.50p |
16:11 | 250,000 @ 2.42p |
CEO | Jeremy Skillington |
CFO | Ian O’Connel |
You are here: research